TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14689 · May 9

#python#comfyui#diffusion_models#dit#image_to_video#image_to_video_generation#text_to_image#text_to_image_generation ComfyUI-LTXVideo is a tool that helps create high-quality videos from images using AI. It offers features like key frame control, improved video quality, and faster generation speeds. This means you can make smooth videos with fewer errors and more control over how they look. It also supports commercial use, so you can use the videos for business projects. The tool is designed to work well with consumer-grade GPUs, making it accessible to more users. Overall, it helps you create professional-looking videos quickly and easily. https://github.com/Lightricks/ComfyUI-LTXVideo

Results

3 similar posts found

Search: #genetherapy

当前筛选 #genetherapy清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3846 · 01/11/2025, 10:00 AM

Funding Rounds Boost Healthcare & Energy Sectors Several companies have recently secured significant funding: - Arizona Public Service: $1.81B, Jan 8, 2025. - Nephron Pharmaceuticals: $350M, Jan 10, 2025. - Windward Bio: $200M, Jan 10, 2025. - Timberlyne Therapeutics: $180M, Jan 10, 2025. - Hippocratic AI: $141M, Jan 9, 2025. - Ouro Medicines: $120M, Jan 10, 2025. - Movement Labs: $100M, Jan 8, 2025. - Rhygaze: $86M, Jan 10, 2025. - Light Horse Therapeutics: $62M, Jan 9, 2025. - Overhaul: $55M, Jan 10, 2025. - Numab: $54.94M, Jan 9, 2025. - Harsoria Healthcare: $20M, Jan 9, 2025. - Huazhi Energy: $13.64M, Jan 8, 2025. - Lava Network: $12M, Jan 9, 2025. - Pakistan Refinery Ltd: $11.24M, Jan 8, 2025. Find detailed updates on respective company websites for more insights. #Funding#Healthcare#Biotech#Energy#Pharmaceuticals#AI#Tech#GeneTherapy#Blockchain#VentureCapital#Investment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform